Black Americans are at higher risk for colorectal cancer than other racial or ethnic groups in the U.S. We can do better, and BOSS is leading the way.
The taskforce is a critical support to address the disparate impact of CRC in the Black community by increasing awareness and improving access to screening and supportive solutions, both during and after diagnosis.
BOSS efforts touch every aspect of a patient's path with colorectal cancer, with an ultimate goal of preventing it in the first place.
Black colorectal cancer patients often face unique barriers delaying their care. BOSS aims to increase colorectal screenings among Black individuals by addressing these disparities.
BOSS has led awareness campaigns, fundraised for research, advocated for under-resourced communities, and provided support.
BOSS and the Alliance plan to collaborate with various stakeholders to boost screenings by creating a sustainable program to detect potential undiagnosed cancers.
Disparities in colorectal screenings within the Black community exist for a few reasons.
American Cancer Society reported that “40 percent of the racial disparity in colon cancer survival is due to the combined effects of the later stage at diagnosis, more unfavorable tumor characteristics, and more comorbidities among black patients” (Lai et al, 2016).
Additional reasons include:
The Alliance is intentionally applying a health equity lens in its approach to improve colorectal screening rates of Black individuals. We partner with those closest to the challenge to identify equitable solutions. Our goal is to save lives and drive lasting impact.
BOSS members are passionate about raising CRC awareness in Black communities. Members can engage in local, regional, and national events, in addition to leadership opportunities.
Colorectal cancer patient Mark Bassett won a Porsche in the Blue Hope Bash car raffle, bringing unexpected joy and new experiences amid his cancer journey.
A new report reveals how 340B program abuse fails low-income patients, increases the federal deficit, and raises employer health plan costs. Congress must act to fix 340B.
The 2024 Jersey Shore Walk to End Colon Cancer raised $58,600 to support the Colorectal Cancer Alliance’s mission and brought together New Jersey area allies to honor, support, and raise awareness for colorectal cancer (CRC). Funds will aid research, screenings, and patient support efforts nationwide.